Latest Breaking News On - Euroendocrine ory es0167733015 - Page 1 : comparemela.com

18 January 2023 ORYZON announces First Patient In in NET, a collaborative Phase II basket study with iadademstat in R/R patients with neuroendocrine carcinomas . | January 18, 2023

United statesComunidad autonoma de catalunaDouglas fallerNamrata vijayvergiaDevelopment agreementUs national cancer instituteNuclear dynamicsCancer epigenetics instituteFox chase cancer centerAssistant chiefGastrointestinal medical oncologyGlobal chief medical officerSmall cell lung cancerAbout iadademstatCancer cellFim phase